BIOMARKERS FOR THE EARLY DIAGNOSIS OF STROKE

Authors

  • Toirova Shahrizoda Sherzod qizi Author

Keywords:

stroke, early diagnosis, biomarkers, ischemic stroke, hemorrhagic stroke, GFAP, S100B, neuroinflammation.

Abstract

Stroke is a major neurological disorder and a leading cause of death and long-term disability worldwide. Early diagnosis is essential for timely treatment and improved outcomes. Although computed tomography and magnetic resonance imaging remain the main diagnostic methods, their limitations in the earliest stages highlight the need for additional approaches. Circulating biomarkers such as GFAP, S100B, NSE, UCH-L1, MMP-9, inflammatory mediators, and microRNAs show potential for early detection, differentiation, and prognostic assessment of stroke. These biomarkers reflect neuronal injury, astrocytic activation, blood–brain barrier disruption, neuroinflammation, and vascular damage. This review summarizes their biological significance, diagnostic potential, and clinical limitations. Further studies are needed to establish standardized thresholds and validate biomarker panels for routine clinical use.

References

1. Powers WJ, Rabinstein AA, Ackerson T, Adeoye OM, Bambakidis NC, Becker K, et al. Guidelines for the Early Management of Patients With Acute Ischemic Stroke: 2019 Update to the 2018 Guidelines for the Early Management of Acute Ischemic Stroke. Stroke. 2019

50(12):e344–e418. doi:10.1161/STR.0000000000000211.

2. Makris K, Haliassos A, Chondrogianni M, Tsivgoulis G. Blood biomarkers in ischemic stroke: Potential role and challenges in clinical practice and research. Critical Reviews in Clinical Laboratory Sciences. 2018

55(5):294–328. doi:10.1080/10408363.2018.1461190.

3. Monbailliu T, Goossens J, Hachimi-Idrissi S. Blood protein biomarkers as diagnostic tool for ischemic stroke: A systematic review. Biomarkers in Medicine. 2017

11(8):701–714. doi:10.2217/bmm-2016-0232.

4. Rahmig J, Chanpura A, Schultz A, Barone F, Gustafson D, Baird A. Blood-based protein biomarkers during the acute ischemic stroke treatment window: A systematic review. Frontiers in Neurology. 2024

15:1411307. doi:10.3389/fneur.2024.1411307.

5. Sjöberg C, et al. Non-coding RNAs versus protein biomarkers to diagnose and differentiate acute stroke: Systematic review and meta-analysis. 2023. PMID: 37778160.

6. Krishnamoorthy S, Singh G, Jose JK, Soman B, Foerch C, Kimberly WT, et al. Biomarkers in the Prediction of Hemorrhagic Transformation in Acute Stroke: A Systematic Review and Meta-Analysis. Cerebrovascular Diseases. 2022

51(2):235–247. doi:10.1159/000518570.

7. Wang L, Wei C, Deng L, et al. The Accuracy of Serum Matrix Metalloproteinase-9 for Predicting Hemorrhagic Transformation After Acute Ischemic Stroke: A Systematic Review and Meta-Analysis. Journal of Stroke and Cerebrovascular Diseases. 2018.

8. Wang Y, et al. Assessment of Serum UCH-L1 and GFAP in Acute Stroke Patients. 2016. PMID: 27074724.

9. Foerch C, Niessner M, Back T, Bauerle M, De Marchis GM, Ferbert A, et al. Diagnostic Accuracy of Glial Fibrillary Acidic Protein and Ubiquitin Carboxy-Terminal Hydrolase-L1 Serum Concentrations for Differentiating Acute Intracerebral Hemorrhage from Ischemic Stroke. 2020. PMID: 32096121.

10. Anand N, Stead LG. Neuron-specific enolase as a marker for acute ischemic stroke: A systematic review. Cerebrovascular Diseases. 2005

20(4):213–219. doi:10.1159/000087701.

11. Coppens S, Lehmann S, Hopley C, Hirtz C. Neurofilament-Light, a Promising Biomarker: Analytical, Metrological and Clinical Challenges. International Journal of Molecular Sciences. 2023

24(14):11624. doi:10.3390/ijms241411624.

12. The role of microRNAs as super-early biomarkers in acute ischemic stroke: A systematic review. Clinical Neurology and Neurosurgery. 2024

244:108416. doi:10.1016/j.clineuro.2024.108416.

13. Shu Y, Qin Y, Fang Q. Research Progress of Blood-Based Biomarkers for the Diagnosis and Prognostic Evaluation of Acute Ischemic Stroke. Biomolecules. 2026

16(7):937. doi:10.3390/biom16070937.

14. Temporal Patterning of Neurofilament Light as a Blood-Based Biomarker for Stroke: A Systematic Review and Meta-Analysis. 2022. PMID: 35651349.

15. Blood neurofilament light chain as a predictive biomarker for functional outcome of acute ischemic stroke: A systematic review and meta-analysis. 2025. PMID: 41054347.

Published

2026-10-02